Navigation Links
GSK Reports PROMACTA(R) (eltrombopag) Significantly Increased Platelet Counts and Reduced Bleeding in Long-Term Study of Patients With Chronic ITP
Date:12/6/2008

After PROMACTA Cessation: Discontinuation of PROMACTA may result in thrombocytopenia of greater severity than was present prior to therapy with PROMACTA. This worsened thrombocytopenia may increase the patient's risk of bleeding, particularly if PROMACTA is discontinued while the patient is on anticoagulants or antiplatelet agents. In the controlled clinical studies, transient decreases in platelet counts to levels lower than baseline were observed following discontinuation of treatment in 10% and 6% of the PROMACTA and placebo groups, respectively. Serious hemorrhagic events requiring the use of supportive ITP medications occurred in 3 severely thrombocytopenic patients within one month following the discontinuation of PROMACTA; none were reported among the placebo group. Following discontinuation of PROMACTA, obtain weekly CBCs, including platelet counts for at least 4 weeks and consider alternative treatments for worsening thrombocytopenia, according to current treatment guidelines.

Thrombotic/Thromboembolic Complications: Thrombotic/thromboembolic complications may result from excessive increases in platelet counts. Excessive doses of PROMACTA or medication errors that result in excessive doses of PROMACTA may increase platelet counts to a level that produces thrombotic/thromboembolic complications. In the controlled clinical studies, one thrombotic/thromboembolic complication was reported within the group that received PROMACTA and none within the placebo group. Seven patients experienced thrombotic/thromboembolic complications in the extension study. Use caution when administering PROMACTA to patients with known risk factors for thromboembolism. To minimize the risk for thrombotic/thromboembolic complications, do not use PROMACTA in an attempt to normalize platelet counts. Follow the dose adjustment guidelines to achieve and maintain a platelet count of greater than or equal to 50,000/microliters.

Malignan
'/>"/>

SOURCE GlaxoSmithKline
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Schering-Plough Reports Preladenant Meets Primary Endpoint in Phase II Dose-Finding Trial for Parkinsons Disease
2. GEN Reports on the Trend Toward Predictive Toxicogenomics
3. Vical Completes Enrollment and Reports Positive Interim Data in CMV Vaccine Phase 2 Trial
4. SCOLR Pharma, Inc. Reports Third Quarter 2008 Financial Results
5. Cadence Pharmaceuticals Reports Third Quarter 2008 Financial Results and Provides Clinical Development Programs Update
6. Bavarian Nordic Reports Successful Safety Data From Phase II Study With IMVAMUNE(R)
7. Rib-X Pharmaceuticals Reports Positive Phase 2 Study Results for Next Generation Oxazolidinone at 2008 ICAAC/IDSA Joint Meeting
8. Paratek Reports Positive Phase 2 Clinical Data on its New Antibiotic PTK 0796 in Late Breaker Presentation at the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy
9. Novexel Reports Positive Phase II Trial Results With NXL103 in Adult Patients With Community Acquired Pneumonia
10. Genmab A/S - Company Announcement: Genmab Reports Results of Portfolio
11. Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2015)... -- Allowing more basic emergency medical service (EMS) staff ... involve opioids, according to a Centers for Disease Control ... Emergency Medical Service Providers and the Burden of Drug ... Journal of Public Health . In 2013, ... States involved prescription opioids, and more than ...
(Date:4/24/2015)... 2015  New technologies and online platforms have ... themselves about products and companies. Likewise, these same ... to market researchers seeking insights into consumer behavior. ... imperative that organizations adjust their consumer marketing playbook ... niches and growth fronts. To ...
(Date:4/24/2015)... 24, 2015 Boston Scientific Corporation (NYSE: BSX ... th Annual Healthcare Conference on May 6 in ... executive vice president and chief financial officer, and Susie ... 35-minute question and answer session regarding the company with the ... live webcast of the presentation and question and answer session ...
Breaking Medicine Technology:Expanding Naloxone use could reduce drug overdose deaths and save lives 2Expanding Naloxone use could reduce drug overdose deaths and save lives 3Pharmaceutical Industry Using New Technologies to Adjust Their Marketing and Research Approaches for Consumers 2Boston Scientific To Participate In The Deutsche Bank 40th Annual Healthcare Conference 2
... , NASHVILLE, Tenn., Nov. 17 Emdeon (NYSE: ... management solutions, today announced that it will participate in the Piper ... to 2, 2009 in New York. , The "fireside chat", featuring ... on Tuesday, December 1, 2009. A live audio webcast will ...
... , ... Board: JGBO) ("Jiangbo" or the "Company"),a pharmaceutical company with its principal ... for its first quarter,of fiscal year 2010 ended September 30, 2009. ... -- Revenues were $24.4 million, ...
Cached Medicine Technology:Jiangbo Pharmaceuticals Announces First Quarter Fiscal Year 2010 Results 2Jiangbo Pharmaceuticals Announces First Quarter Fiscal Year 2010 Results 3Jiangbo Pharmaceuticals Announces First Quarter Fiscal Year 2010 Results 4Jiangbo Pharmaceuticals Announces First Quarter Fiscal Year 2010 Results 5Jiangbo Pharmaceuticals Announces First Quarter Fiscal Year 2010 Results 6Jiangbo Pharmaceuticals Announces First Quarter Fiscal Year 2010 Results 7Jiangbo Pharmaceuticals Announces First Quarter Fiscal Year 2010 Results 8Jiangbo Pharmaceuticals Announces First Quarter Fiscal Year 2010 Results 9Jiangbo Pharmaceuticals Announces First Quarter Fiscal Year 2010 Results 10Jiangbo Pharmaceuticals Announces First Quarter Fiscal Year 2010 Results 11Jiangbo Pharmaceuticals Announces First Quarter Fiscal Year 2010 Results 12Jiangbo Pharmaceuticals Announces First Quarter Fiscal Year 2010 Results 13Jiangbo Pharmaceuticals Announces First Quarter Fiscal Year 2010 Results 14
(Date:4/25/2015)... New York (PRWEB) April 25, 2015 The ... Dr. Jerry Blaivas has been chosen by the New York ... his contributions to medicine in the field of Urology. , ... best in his speciality, Genito-Urinary diseases. He was a ... in the field of urology. Not only did he ...
(Date:4/24/2015)... CA (PRWEB) April 24, 2015 Bird B ... and residential applications now offers a complete line of bird ... to poultry farms. , New Flu Strains Threaten Pacific, Central ... 2015 USDA post , a number of highly pathogenic ... paths. The disease is often spread when wild birds enter ...
(Date:4/24/2015)... April 24, 2015 Ryadon is a ... range of capabilities and services to complement any custom ... Quantity Discount Program will be offered on all heavy ... Order 4-19: Receive 10% discount - Order 20+: Receive ... the Drawer Slides Products, Furniture ...
(Date:4/24/2015)... The 1975 have had an intense ... globe to theaters, festivals and TV performances. Now that they’ve ... their label, Dirty Hit Records, to provide clean drinking water ... launched Cadence & Cause website, this four-piece has ... and a signed photo card. Entries from this sweepstakes ...
(Date:4/24/2015)... (PRWEB) April 24, 2015 Carinsurancequotesinfo.com has ... blog post explaining how to qualify for auto ... parents can qualify for auto insurance online, without having ... post explains that single parents can reduce their auto ... released article and properly explained. , Clients can ...
Breaking Medicine News(10 mins):Health News:The 2015 Valentine Award Comes From The Heart and Goes To Famous New York Urologist 2Health News:The 2015 Valentine Award Comes From The Heart and Goes To Famous New York Urologist 3Health News:Bird B Gone Offers Solutions to Bird Flu Threat to Poultry Farms 2Health News:Bird B Gone Offers Solutions to Bird Flu Threat to Poultry Farms 3Health News:Bird B Gone Offers Solutions to Bird Flu Threat to Poultry Farms 4Health News:Ryadon Inc. Offers Quantity Drawer Slide Discount Program Nationwide in May 2015 2Health News:Ryadon Inc. Offers Quantity Drawer Slide Discount Program Nationwide in May 2015 3Health News:Internationally Recognized British Indie Rock Outfit The 1975 Partner with Cadence & Cause to Provide Clean Drinking Water to Those in Need 2Health News:Auto Insurance Discounts for Single Parents - How to Qualify for Low Rates 2
... Seniors with low incomes are more likely to develop heart ... Medicare coverage and are college-educated, a new study finds. ... concerned, lower education may not matter if a person is ... senior researcher Dr. Ali Ahmed, in an American Heart Association ...
... Hospitals that do not have cardiac surgery capability can ... hospitals that do offer cardiac surgery. That is the ... to assess whether patients do just as well having ... not offer cardiac surgery. Results of the study, ...
... Glioblastoma multiforme in the Dock Glioblastoma multiforme ... Patients with GBM have a poor prognosis because it is ... to current therapies. A team of researchers led by ... Cancer Institute, Pittsburgh has now identified a molecular pathway ...
... Nov. 14 (HealthDay News) -- Aggression in childhood is associated ... a health risk, a new study says. Researchers tracked ... who were in first, fourth and seventh grades in the ... and 2006. The results showed that childhood aggression was ...
... year and a year can feel like an eternity. With very ... Administration for this condition since 2005, the outlook is far from ... to $4.5 million in funding from the agency over the next ... study different approaches to improve the methods used to evaluate and ...
... of Granada researchers have proven that infants born to women ... weight at birth than those born to mothers living in ... to xenoestrogens, a type of environmental pollutants that act like ... establishing a correlation between estrogenic burden in pregnant women,s placenta ...
Cached Medicine News:Health News:Low-Income Seniors at Greater Risk for Heart Failure 2Health News:Patients fare just as well if their nonemergency angioplasty is performed at hospitals 2Health News:Patients fare just as well if their nonemergency angioplasty is performed at hospitals 3Health News:JCI online early table of contents: Nov. 14, 2011 2Health News:JCI online early table of contents: Nov. 14, 2011 3Health News:JCI online early table of contents: Nov. 14, 2011 4Health News:JCI online early table of contents: Nov. 14, 2011 5Health News:JCI online early table of contents: Nov. 14, 2011 6Health News:Childhood Aggression May Predict Health Woes in Adulthood 2Health News:FDA funds Rochester researchers to give chronic and acute pain clinical trials a makeover 2Health News:FDA funds Rochester researchers to give chronic and acute pain clinical trials a makeover 3Health News:Prenatal exposure to environmental pollutants determines weight and size at birth 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: